DYN:NASDAQ
Dyne Therapeutics, Inc
$19.19
arrow_downward
-5.51%(-1.12) 1D
$19.16
arrow_downward
-0.15% (-0.028)bedtimeAfter hours
Closed: Sep 9, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DYN...
Open
$19.38
High
$20.16
Low
$18.97
Mkt. cap
3.58B
Avg. vol.
2.32M
Volume
0.00
52-wk high
$27.30
52-wk low
$11.92
EPS
-$3.33
Beta
1.08
Shares outstanding
186.75M
No. of employees
289
Open
$19.38
High
$20.16
Low
$18.97
Mkt. cap
3.58B
Avg. vol.
2.32M
Volume
0.00
52-wk high
$27.30
52-wk low
$11.92
EPS
-$3.33
Beta
1.08
Shares outstanding
186.75M
No. of employees
289
News stories
From web sources and news partners
Stocktwits
·
1 hour ago
Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes
Investing.com
·
16 hours ago
Dyne Therapeutics stock price target lowered to $30 by RBC Capital
Seeking Alpha
·
17 hours ago
Dyne Therapeutics Remains A Buy Even As Novartis Trial Failure Hits DM1 Class (NASDAQ:DYN)
TipRanks
·
17 hours ago
Dyne Therapeutics Slumps As Analysts Turn Cautious
About Dyne Therapeutics, Inc
CEO-
Employees289
Founded2017
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitedyne-tx.com